Wednesday, March 29, 2023 | Back issues
Courthouse News Service Courthouse News Service

Shareholder Class Action

SAN DIEGO - Shareholders say Anadys Pharmaceuticals is selling itself too cheaply to Hoffman-La Roche, for $230 million or $3.70 a share.

Read the Top 8

Sign up for the Top 8, a roundup of the day's top stories delivered directly to your inbox Monday through Friday.